Emmessar Biotech & Nutrition submits copy of revised financial results

26 Dec 2015 Evaluate

Emmessar Biotech & Nutrition has submitted a copy of the Revised Financial Results for the period ended September 30, 2015 with the necessary corrections duly done in Profit Before Tax in the Segment wise section.

The above information is a part of company’s filings submitted to BSE.

 

 

 

Emmessar Biotech&Nut Share Price

40.28 1.91 (4.98%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.